Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01240408 · ClinicalTrials.gov registry record · Phase 1
E7080 Food Effect Study in Healthy Subjects
A Phase 1 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT01240408 is a Phase 1 study that has completed, run by Eisai. The registered enrollment target is 16 participants.
The verdict
NCT01240408, a Phase 1 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
This will be a randomized, single-dose, open-label, two-period crossover study in 16 healthy subjects. The study will consist of two phases: Pre-randomization and Randomization. The Pre-randomization phase will have two periods: Screening and Baseline. In the Randomization Phase, subjects will be randomized to one of two possible treatment sequences (fed/fasted and fasted/fed). In each period, subjects will receive a single capsule containing 10 mg lenvatinib either with or without a standard breakfast. There will be a 2-week washout between treatments.
Interventions
- DRUG HOPE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2010-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01240408
The ClinicalTrials.gov registry entry for NCT01240408 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HOPE is the first listed.
NCT01240408 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01240408 about?
NCT01240408 is a clinical study titled "E7080 Food Effect Study in Healthy Subjects". This will be a randomized, single-dose, open-label, two-period crossover study in 16 healthy subjects. The study will consist of two phases: Pre-randomization and Randomization. The Pre-randomization phase will have two periods: Screening and Baseline. In the Randomization Phase, subjects will be ra...
What is the current status of trial NCT01240408?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2010-07.
What interventions are being tested in trial NCT01240408?
The interventions under investigation include: HOPE (DRUG).
Who is sponsoring clinical trial NCT01240408?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.